AVATAR MEDICAL receives FDA clearance for its VR surgical planning solution

In Virtual Reality News

June 8, 2023 – AVATAR MEDICAL, a medtech startup offering a solution that allows for the creation of patient avatars to help surgeons visualize medical images, has this week announced that its virtual reality (VR) surgical planning solution has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).

AVATAR MEDICAL helps surgeons better prepare their procedures through the use of VR representations of patients. Patient avatars are generated instantly from CT scan or MRI images with an underlying proprietary technology. These avatars can then serve as valuable tools for pre-operative planning and can also be displayed during surgical procedures.

According to AVATAR MEDICAL, more than 100 surgeons from 20 different hospitals and universities, including UMass, CUNY and Columbia University, have benefited from the company’s solution. To date, it has been used for case studies, student education and patient engagement, leading to 6 medical publications.

“After receiving tremendous positive feedback from surgeons over the past 3 years, the FDA’s clearance is a major milestone in getting our VR solution in their hands to care for their patients. We expect European medical device certification for next year,” said Xavier Wartelle, CEO of AVATAR MEDICAL.

Commenting on the company’s platform, Venkatesh Krishnasamy MD, Interventional Radiology, Associate Professor of Radiology, Columbia University, stated: “AVATAR MEDICAL is a unique hardware agnostic XR software platform. With the ability to plan based on preoperative imaging and then evaluate as well as confirm based on intraoperative imaging, I now have an additional level of capability and confidence in my advanced percutaneous and endovascular interventions.”

For more information on AVATAR MEDICAL and its VR surgical planning and patient avatar solution, please visit the company’s website.

Image credit: AVATAR MEDICAL

About the author

Sam Sprigg

Sam is the Founder and Managing Editor of Auganix. With a background in research and report writing, he has been covering XR industry news for the past seven years.